rs10455840

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_031924.8(RSPH3):​c.767G>A​(p.Arg256Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0213 in 1,614,062 control chromosomes in the GnomAD database, including 415 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.018 ( 34 hom., cov: 32)
Exomes 𝑓: 0.022 ( 381 hom. )

Consequence

RSPH3
NM_031924.8 missense

Scores

4
14

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:4

Conservation

PhyloP100: 0.792

Publications

12 publications found
Variant links:
Genes affected
RSPH3 (HGNC:21054): (radial spoke head 3) The protein encoded by this gene acts as a protein kinase A anchoring protein. Mutations in this gene cause primary ciliary dyskinesia; a disorder characterized by defects of the axoneme in motile cilia and sperm flagella. The homolog of this gene was first identified in the blue-green algae Chlamydomonas as encoding a radial spoke protein that formed a structural component of motile cilia and flagella. Alternate splicing results in multiple transcript variants encoding distinct isoforms. [provided by RefSeq, Dec 2016]
RSPH3 Gene-Disease associations (from GenCC):
  • primary ciliary dyskinesia 32
    Inheritance: AR Classification: DEFINITIVE, STRONG, MODERATE Submitted by: Labcorp Genetics (formerly Invitae), G2P, PanelApp Australia, Ambry Genetics
  • primary ciliary dyskinesia
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0036847591).
BP6
Variant 6-158980866-C-T is Benign according to our data. Variant chr6-158980866-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 475820.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.0178 (2709/152254) while in subpopulation NFE AF = 0.0237 (1612/68012). AF 95% confidence interval is 0.0227. There are 34 homozygotes in GnomAd4. There are 1287 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 34 AR,AD gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
RSPH3NM_031924.8 linkc.767G>A p.Arg256Gln missense_variant Exon 6 of 8 ENST00000367069.7 NP_114130.4 Q86UC2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
RSPH3ENST00000367069.7 linkc.767G>A p.Arg256Gln missense_variant Exon 6 of 8 1 NM_031924.8 ENSP00000356036.1 A0A0C4DFU3
RSPH3ENST00000449822.6 linkc.479G>A p.Arg160Gln missense_variant Exon 4 of 6 2 ENSP00000393195.1 A0A0C4DG29

Frequencies

GnomAD3 genomes
AF:
0.0178
AC:
2707
AN:
152136
Hom.:
34
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00929
Gnomad AMI
AF:
0.0934
Gnomad AMR
AF:
0.0234
Gnomad ASJ
AF:
0.00662
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00850
Gnomad FIN
AF:
0.0155
Gnomad MID
AF:
0.0253
Gnomad NFE
AF:
0.0237
Gnomad OTH
AF:
0.0158
GnomAD2 exomes
AF:
0.0167
AC:
4211
AN:
251470
AF XY:
0.0171
show subpopulations
Gnomad AFR exome
AF:
0.00886
Gnomad AMR exome
AF:
0.0145
Gnomad ASJ exome
AF:
0.00695
Gnomad EAS exome
AF:
0.000326
Gnomad FIN exome
AF:
0.0164
Gnomad NFE exome
AF:
0.0229
Gnomad OTH exome
AF:
0.0171
GnomAD4 exome
AF:
0.0216
AC:
31621
AN:
1461808
Hom.:
381
Cov.:
31
AF XY:
0.0213
AC XY:
15456
AN XY:
727206
show subpopulations
African (AFR)
AF:
0.0101
AC:
339
AN:
33478
American (AMR)
AF:
0.0152
AC:
680
AN:
44722
Ashkenazi Jewish (ASJ)
AF:
0.00746
AC:
195
AN:
26136
East Asian (EAS)
AF:
0.000227
AC:
9
AN:
39696
South Asian (SAS)
AF:
0.0127
AC:
1096
AN:
86250
European-Finnish (FIN)
AF:
0.0155
AC:
830
AN:
53420
Middle Eastern (MID)
AF:
0.0248
AC:
143
AN:
5766
European-Non Finnish (NFE)
AF:
0.0245
AC:
27200
AN:
1111946
Other (OTH)
AF:
0.0187
AC:
1129
AN:
60394
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.471
Heterozygous variant carriers
0
1514
3028
4542
6056
7570
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
1016
2032
3048
4064
5080
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0178
AC:
2709
AN:
152254
Hom.:
34
Cov.:
32
AF XY:
0.0173
AC XY:
1287
AN XY:
74452
show subpopulations
African (AFR)
AF:
0.00931
AC:
387
AN:
41552
American (AMR)
AF:
0.0233
AC:
357
AN:
15292
Ashkenazi Jewish (ASJ)
AF:
0.00662
AC:
23
AN:
3472
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5178
South Asian (SAS)
AF:
0.00851
AC:
41
AN:
4820
European-Finnish (FIN)
AF:
0.0155
AC:
164
AN:
10610
Middle Eastern (MID)
AF:
0.0238
AC:
7
AN:
294
European-Non Finnish (NFE)
AF:
0.0237
AC:
1612
AN:
68012
Other (OTH)
AF:
0.0156
AC:
33
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
141
283
424
566
707
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
32
64
96
128
160
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0213
Hom.:
124
Bravo
AF:
0.0179
TwinsUK
AF:
0.0213
AC:
79
ALSPAC
AF:
0.0236
AC:
91
ESP6500AA
AF:
0.0113
AC:
50
ESP6500EA
AF:
0.0245
AC:
211
ExAC
AF:
0.0167
AC:
2026
Asia WGS
AF:
0.00491
AC:
17
AN:
3478
EpiCase
AF:
0.0250
EpiControl
AF:
0.0240

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:4
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Primary ciliary dyskinesia 32 Benign:2
Jan 30, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 09, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not provided Benign:2
Oct 13, 2020
GeneDx
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.085
BayesDel_addAF
Benign
-0.59
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
14
DANN
Uncertain
0.99
DEOGEN2
Benign
0.056
T;.;T
Eigen
Benign
-0.85
Eigen_PC
Benign
-0.96
FATHMM_MKL
Benign
0.12
N
LIST_S2
Uncertain
0.86
D;D;D
MetaRNN
Benign
0.0037
T;T;T
MetaSVM
Benign
-0.97
T
MutationAssessor
Uncertain
2.1
.;.;M
PhyloP100
0.79
PrimateAI
Benign
0.21
T
PROVEAN
Uncertain
-2.6
D;D;D
REVEL
Benign
0.037
Sift
Benign
0.22
T;T;T
Sift4G
Benign
0.15
T;T;T
Polyphen
0.10
.;.;B
Vest4
0.12
MPC
0.39
ClinPred
0.025
T
GERP RS
-0.62
Varity_R
0.053
gMVP
0.57
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10455840; hg19: chr6-159401898; COSMIC: COSV51925443; COSMIC: COSV51925443; API